We investigated potential markers of susceptibility to tinnitus in a group of normal hearing young pilots aged 25–35 years and with 8 ± 5 years of aircraft noise exposure. 316 pilots were interviewed about their tinnitus status and were tested for hearing thresholds (audiograms) and distortion products otoacoustic emissions (DPOAE-grams). There was no subject with permanent tinnitus. 23% reported having occasionally perceived tinnitus after flight missions and 77% reported never having experienced tinnitus after flight missions. General discomfort in the ears to noise was higher in the occasional tinnitus group (15 vs. 6%). The major finding was that difference of susceptibility to tinnitus in normal hearing subjects exposed to noise on a daily basis seemed to be clearly related to lower DPOAEs, bilaterally, in the 1500- to 2800-kHz range. However, no difference could be observed between groups on audiograms at the 2-kHz frequency range. This study provided evidence of outer hair cell dysfunctions in normal hearing subjects exposed to noise and susceptible to tinnitus. Hypersensitivity to noise and decreased DPOAEs in a non-noise-specific frequency range support the idea of another alteration mechanism than noise itself. This point was discussed in the light of recent publications.

Keywords:
Susceptibility to tinnitus, pilots, Aircraft noise exposure, Distortion products otoacoustic emissions, DP-grams, DPOAE-grams, Hearing levels
1.
Alberts DS, Noel JK: Cisplatin-associated neurotoxicity: Can it be prevented? Anticancer Drugs 1995;6:369–383.
2.
Axelsson A, Barrenäs ML: Tinnitus in noise-induced hearing loss; in Dancer A, Henderson D, Salvi R, Hamernik RP (eds): Noise-Induced Hearing Loss. St Louis, Mosby-Year Book, 1992, pp 272–273.
3.
Bonfils P, Piron JP, Uziel A: A correlative study of evoked otoacoustic emission properties and audiometric thresholds. Arch Otorhinolaryngol 1988;245:53–56.
4.
Collet L, Morgon A, Veuillet E, Gartner M: Noise and medial olivocochlear system in Human. Acta Otolaryngol 1991;111:231–233.
5.
Dietrich V, Nieschalk M, Stoll W, Rajan R, Pantev C: Cortical reorganization in patients with high frequency cochlear hearing loss. Hear Res 2001;158:95–101.
6.
Huang ZW, Luo Y, Wu Z, Tao Z, Jones RO, Zhao HB: Paradoxical enhancement of active cochlear mechanics in long-term administration of salicylate. J Neurophysiol 2005;93:2053–2061.
7.
ISO 389: Acoustics – Standard Reference Zero for Calibration of Pure-Tone Audiometers. Geneva, International Organization for Standardization, 1975.
8.
ISO 389 AD1: Addendum No. 1 to ISO 389/1975. Geneva, International Organization for Standardization, 1983.
9.
Jastreboff PJ: Phantom auditory perception (tinnitus): mechanisms of generation and perception. Neurosci Res 1990;8:221–254.
10.
Job A, Cian C, Esquivié D, Leifflen D, Trousselard M, Charles C, Nottet JB: Moderate variations of mood/emotional states related to alterations in cochlear otoacoustic emissions and tinnitus onset in young normal hearing subjects exposed to gun impulse noise. Hear Res 2004;193:31–38.
11.
Lockwood AH, Salvi RJ, Burkard RF: Tinnitus. N Engl J Med 2002;347:904–910.
12.
Man A, Naggan L: Characteristics of tinnitus in acoustic trauma. Audiology 1981;20:72–78.
13.
Martin GK, Ohlms LA, Franklin D, Harris FP, Lonsbury-Martin BL: Distortion product emissions in humans. III. Influence of sensorineural hearing loss. Ann Otol Rhinol Laryngol 1990;99:30–42.
14.
Mrena R, Savolainen S, Kuokkanen JT, Ylikoski J: Characteristics of tinnitus induced by acute acoustic trauma: a long-term follow-up. Audiol Neurootol 2002;7:122–130.
15.
Mühlnickel V, Elbert T, Taub E, Flor H: Reorganization of auditory cortex in tinnitus. Proc Natl Acad Sci USA 1998;95:10340–10343.
16.
Nottet JB, Moulin A, Brossard N, Suc B, Job A: Otoacoustic emissions and persistent tinnitus after acute acoustic trauma. Laryngoscope 2006;116:970–975.
17.
Onishi ET, Fukuda Y, Suzuki FA: Distortion product otoacoustic emissions in tinnitus patients. Int Tinnitus J 2004;10:13–16.
18.
Plinkert PK, Hemme W, Zenner HP: Comparison of methods for early detection of noise vulnerability of the inner ear: amplitude reduction of otoacoustic emissions are most sensitive at submaximal noise impulse exposure. HNO 1995;43:89–97.
19.
Popiech L, Sztuka-Pietkiewicz A, Jablonka A, Orendorz-Fraczkowska K: DPOAEs in patients with tinnitus and normal hearing. Otolaryngol Pol 2003;57:905–910.
20.
Raynal M, Kossowski M, Job A: Hearing in military pilots: one-time audiometry in pilots of fighters, transports and helicopters. Aviat Space Environ Med 2006;77:57–61.
21.
Shiomi Y, Tsuji J, Naito Y, Fujiki N, Yamamoto N: Characteristics of DPOAE audiogram in tinnitus patients. Hear Res 1997;108:83–88.
22.
Smurzynski J, Leonard G, Kim DO, Lafrenière DC, Jung MD: Distortion product otoacoustic emissions in normal and impaired adults ears. Arch Otolaryngol Head Neck Surg 1990;116:1309–1316.
23.
Wagner W, Plinkert PK: The relationship between auditory threshold and evoked otoacoustic emissions. Eur Arch Otorhinolaryngol 1999;256:177–188.
24.
Yantis PA: Audiology; in Cleve, JV (ed): Gallaudet Encyclopedia of Deaf People and Deafness. Vol 1, A–G. New York, McGraw-Hill Book Company, Inc, 1987, pp 40–44.
25.
Zheng XY, Henderson D, Hu BH, Ding DL, McFadden SL: The influence of the cochlear efferent system on chronic acoustic trauma. Hear Res 1997;107:147–159.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.